CAR-T Safe in Myeloma Patients With Autoimmune Diseases, Small Study Finds

(MedPage Today) — A retrospective study presented at the recent American Society of Clinical Oncology (ASCO) meeting suggested that patients with autoimmune diseases may safely receive idecabtagene vicleucel (ide-cel; Abecma) for relapsed or refractory…

Source link : https://www.medpagetoday.com/meetingcoverage/ascovideopearlsmm/116052

Author :

Publish date : 2025-06-13 12:40:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

CAR-T Safe in Myeloma Patients With Autoimmune Diseases, Small Study Finds

Lymphoma: Dual-Targeting CAR T Shows Safety, Efficacy

Cardiac Risk Warning for Lamotrigine Challenged

Related Posts

3D-printed electronics can dissolve in water for quick recycling

Risk of Malignant Tumor Rises After Traumatic Brain Injury

Study Examines Off-Target Mortality in Cancer Screening

Low-Cal Mediterranean Diet Plus Exercise Linked to Less Diabetes Onset

Expect Health Insurance Prices to Rise Next Year, Brokers and Experts Say

Potent Cannabis Products Linked to Psychosis, Mental Health Risks

3D-printed electronics can dissolve in water for quick recycling

Risk of Malignant Tumor Rises After Traumatic Brain Injury

Study Examines Off-Target Mortality in Cancer Screening

Low-Cal Mediterranean Diet Plus Exercise Linked to Less Diabetes Onset

Expect Health Insurance Prices to Rise Next Year, Brokers and Experts Say

Potent Cannabis Products Linked to Psychosis, Mental Health Risks

Just How Long Should RA Patients Be Checked for Drug Toxicity?

Very Abnormal Results Rare in DMARD Toxicity Monitoring

Categories

Archives